Maria N Barrachina

6PUBLICATIONS
25CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Medical biochemistry - lipidsProteins and peptidesCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 15, 2025
Major histocompatibility complex class II-expressing bone marrow megakaryocytes activate CD4+ T cells and induce regulatory T cell fate.

Virginia Camacho, Karen G Wang, Pavel Hanč

|Dec 16, 2024
Inhibition of RhoA-mediated secretory autophagy in megakaryocytes mitigates myelofibrosis in mice.

Isabelle C Becker, Maria N Barrachina, Joshua Lykins

|Aug 12, 2022
Platelet Lipidome Fingerprint: New Assistance to Characterize Platelet Dysfunction in Obesity.

Gaëtan Chicanne, Maria N Barrachina, Anaelle Durbec

|Feb 16, 2022
Katacine Is a New Ligand of CLEC-2 that Acts as a Platelet Agonist.

Luis A Morán, Ying Di, Marcin A Sowa

|Sep 29, 2021
The bone marrow niche from the inside out: how megakaryocytes are shaped by and shape hematopoiesis.

Andrew P Stone, Thais F Nascimento, Maria N Barrachina

|Apr 03, 2021
The PI3Kδ Inhibitor Idelalisib Diminishes Platelet Function and Shows Antithrombotic Potential.

María N Barrachina, Irene Izquierdo, Lidia Hermida-Nogueira

Pageof 1